CSIMarket Company Name, Ticker, Customers, else..
 
Neumora Therapeutics Inc   (NASDAQ: NMRA)
 

Neumora Therapeutics Inc's Suppliers Performance

NMRA's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
NMRA Costs vs Sales of Suppliers Growth

• More on NMRA Suppliers






Neumora Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, drug substances, and drug products for preclinical research and clinical trials from various contract manufacturing organizations (CMOs). Among these, the drug substance supplier for navacaprant and the drug product suppliers for the navacaprant and NMRA-511 programs are single-source suppliers. These single-source suppliers are bound by agreements that cannot be terminated for convenience, and there are no minimum purchase commitments. The company intends to continue relying on CMOs for later-stage development and commercialization of its product candidates. It employs personnel and third-party consultants with extensive manufacturing experience to manage relationships with contract manufacturers.

Neumora Therapeutics Inc's Comment on Supply Chain


The company sources raw materials, drug substances, and drug products for preclinical research and clinical trials from various contract manufacturing organizations (CMOs). Among these, the drug substance supplier for navacaprant and the drug product suppliers for the navacaprant and NMRA-511 programs are single-source suppliers. These single-source suppliers are bound by agreements that cannot be terminated for convenience, and there are no minimum purchase commitments. The company intends to continue relying on CMOs for later-stage development and commercialization of its product candidates. It employs personnel and third-party consultants with extensive manufacturing experience to manage relationships with contract manufacturers.







NMRA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Neumora Therapeutics Inc 125.91 0.00 -212.75 96
SUBTOTAL 0.00 0.00 0.00 -


Sources: Neumora Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Neumora Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.